Condition: Breast Cancer · Lung Cancer · Multiple Myeloma · Sponsor: Carevive Systems, Inc.
The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.
This description comes directly from the study's public registry record.
JULIE SCOTT, MSN · 8778423210 · Julie.Scott@Carevive.com
Always discuss trial participation with your own doctor first.
| Yale Cancer Center | New Haven, Connecticut, United States | Completed |
| Northshore University Health System | Evanston, Illinois, United States | Recruiting |
| Univeristy of North Carolina at Chapel Hill | Chapel Hill, North Carolina, United States | Completed |
| Duke | Durham, North Carolina, United States | Completed |
| Cleveland Clinic Mercy Hospital | Canton, Ohio, United States | Recruiting |
| University Hospitals Seidman Cancer Center | Cleveland, Ohio, United States | Recruiting |
| Tri-County Hematology & Oncology Associates, Inc. | Massillon, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05974150